KYIV. March 27 (Interfax-Ukraine) – PJSC Borschahivsky chemical pharmaceutical plant plans by the end of 2018 to invest UAH 317 million in modernization of production, according to a company press release, with reference to its commercial director Yevhen Sova.
“Despite the difficult economic situation in the country, we continue implementing our plans and investing in our development. We plan by the end of 2018 to invest UAH 317 million in modernization of production,” he said.
In addition, the press release says Credit-Rating agency affirmed the long-term credit rating of the plant.
As reported, in 2016 the plant doubled net profit from 2015, to UAH 118.702 million. In 2015 its net profit increased by 35%, to UAH 59.3 million.
In 2016 the plant entered the top ten in terms of pharmacy sales: it occupied 4.2% of the market.
In March 2015, Kyiv sold its 30% stake in Borschahivsky chemical pharmaceutical plant to Darnytsia pharmaceutical firm (Kyiv) for UAH 171.844 million.
